Browsing Category

43961 posts

Owlish Online Strengthens GEO Services to Help Hong Kong Businesses Gain Early Visibility in AI Search

With more than 300 corporate clients served, the company extends its SEO expertise…
The American Hotel Owners Charitable Association (AHOCA) Officially Launches Its Asia Chapter in Hong Kong, Creating a Unified Platform to Connect Industry Leaders in the US and Asia

The American Hotel Owners Charitable Association (AHOCA) Officially Launches Its Asia Chapter in Hong Kong, Creating a Unified Platform to Connect Industry Leaders in the US and Asia

HONG KONG, May 22, 2026 /PRNewswire/ — The America Hotel Owners Charitable…
Riverchain Partners with Micro Connect to Scale Working Capital for Construction Contractors

Riverchain Partners with Micro Connect to Scale Working Capital for Construction Contractors

HONG KONG, May 22, 2026 /PRNewswire/ — Riverchain International Limited ("Riverchain" or…
LRQA Calls for Stronger AI Governance and Cyber Resilience Frameworks at CyberSecMY 2026

LRQA Calls for Stronger AI Governance and Cyber Resilience Frameworks at CyberSecMY 2026

KUALA LUMPUR, Malaysia, May 22, 2026 /PRNewswire/ — With AI rapidly reshaping…

BAI Capital Announces First Close of New US$800 Million Fund, Continues to Back Asia Growth and Globalization Opportunities

BEIJING, May 22, 2026 /PRNewswire/ — BAI Capital today announced the first…

ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond

MEXICO CITY, May 22, 2026 /PRNewswire/ — ESENTIA Energy Development, S.A.B. de C.V. (BMV:…
Digital Edge Successfully Closes First US5 Million HoldCo Loan to Accelerate Growth Across Key Asia-Pacific Markets

Digital Edge Successfully Closes First US$575 Million HoldCo Loan to Accelerate Growth Across Key Asia-Pacific Markets

SINGAPORE, May 22, 2026 /PRNewswire/ — Digital Edge today announced the successful…

Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026

Sacituzumab tirumotecan (sac-TMT)(佳泰莱®) plus pembrolizumab versus pembrolizumab as first-line treatment for PD-L1…